These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26010212)

  • 1. Plasma antioxidant status and motor features in de novo Chinese Parkinson's disease patients.
    Yuan Y; Tong Q; Zhang L; Jiang S; Zhou H; Zhang R; Zhang S; Xu Q; Li D; Zhou X; Ding J; Zhang K
    Int J Neurosci; 2016; 126(7):641-6. PubMed ID: 26010212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum glutathione peroxidase, xanthine oxidase, and superoxide dismutase activities and malondialdehyde levels in patients with Parkinson's disease.
    Gökçe Çokal B; Yurtdaş M; Keskin Güler S; Güneş HN; Ataç Uçar C; Aytaç B; Durak ZE; Yoldaş TK; Durak İ; Çubukçu HC
    Neurol Sci; 2017 Mar; 38(3):425-431. PubMed ID: 27900485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study on changes of plasma levels of oxidative stress biomarkers and its relation with cognition function in patients with parkinson's disease].
    Zhou H; Yuan Y; Qi Z; Tong Q; Zhang K
    Zhonghua Yi Xue Za Zhi; 2015 Nov; 95(41):3357-60. PubMed ID: 26812976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the plasma levels of neurodegenerative proteins and motor subtypes of Parkinson's disease.
    Ding J; Zhang J; Wang X; Zhang L; Jiang S; Yuan Y; Li J; Zhu L; Zhang K
    J Neural Transm (Vienna); 2017 Mar; 124(3):353-360. PubMed ID: 27878377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte antioxidant enzymes in Parkinson's disease.
    Abraham S; Soundararajan CC; Vivekanandhan S; Behari M
    Indian J Med Res; 2005 Feb; 121(2):111-5. PubMed ID: 15756044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How stable are Parkinson's disease subtypes in de novo patients: Analysis of the PPMI cohort?
    Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Tanner C; Marek K;
    Parkinsonism Relat Disord; 2016 Jul; 28():62-7. PubMed ID: 27132498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood markers of oxidative stress in Parkinson's disease.
    Younes-Mhenni S; Frih-Ayed M; Kerkeni A; Bost M; Chazot G
    Eur Neurol; 2007; 58(2):78-83. PubMed ID: 17565220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distal motor deficit contributions to postural instability and gait disorder in Parkinson's disease.
    Vervoort G; Bengevoord A; Nackaerts E; Heremans E; Vandenberghe W; Nieuwboer A
    Behav Brain Res; 2015; 287():1-7. PubMed ID: 25804361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid amyloid-β and phenotypic heterogeneity in de novo Parkinson's disease.
    Alves G; Pedersen KF; Bloem BR; Blennow K; Zetterberg H; Borm GF; Dalaker TO; Beyer MK; Aarsland D; Andreasson U; Lange J; Tysnes OB; Zivadinov R; Larsen JP
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):537-43. PubMed ID: 23117496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory motor dysfunction in parkinson's disease subtypes.
    Gong T; Xiang Y; Saleh MG; Gao F; Chen W; Edden RAE; Wang G
    J Magn Reson Imaging; 2018 Jun; 47(6):1610-1615. PubMed ID: 28960581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Free radical toxicity and antioxidants in Parkinson's disease.
    Sudha K; Rao AV; Rao S; Rao A
    Neurol India; 2003 Mar; 51(1):60-2. PubMed ID: 12865518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of oxidative stress in patients with alopecia areata and its relationship with disease severity, duration, recurrence and pattern.
    Yenin JZ; Serarslan G; Yönden Z; Ulutaş KT
    Clin Exp Dermatol; 2015 Aug; 40(6):617-21. PubMed ID: 25524272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Highly specific changes in antioxidant levels and lipid peroxidation in Parkinson's disease and its progression: Disease and staging biomarkers and new drug targets.
    de Farias CC; Maes M; Bonifácio KL; Bortolasci CC; de Souza Nogueira A; Brinholi FF; Matsumoto AK; do Nascimento MA; de Melo LB; Nixdorf SL; Lavado EL; Moreira EG; Barbosa DS
    Neurosci Lett; 2016 Mar; 617():66-71. PubMed ID: 26861200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum uric acid level and its association with motor subtypes and non-motor symptoms in early Parkinson's disease: PALS study.
    Huang X; Ng SY; Chia NS; Acharyya S; Setiawan F; Lu ZH; Ng E; Tay KY; Au WL; Tan EK; Tan LC
    Parkinsonism Relat Disord; 2018 Oct; 55():50-54. PubMed ID: 29779681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma lipid peroxidation and antioxidant status of Parkinson's disease patients in the Indian population.
    Sharma A; Kaur P; Kumar B; Prabhakar S; Gill KD
    Parkinsonism Relat Disord; 2008; 14(1):52-7. PubMed ID: 18032086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter changes and the development of motor phenotypes in de novo Parkinson's Disease.
    Moccia M; Tedeschi E; Ugga L; Erro R; Picillo M; Caranci F; Barone P; Brunetti A
    J Neurol Sci; 2016 Aug; 367():215-9. PubMed ID: 27423590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and antioxidant enzyme activity in South Indian male smokers with chronic obstructive pulmonary disease.
    Arja C; Surapaneni KM; Raya P; Adimoolam C; Balisetty B; Kanala KR
    Respirology; 2013 Oct; 18(7):1069-75. PubMed ID: 23683270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress: correlation with Behçet's disease duration, activity and severity.
    Harzallah O; Kerkeni A; Baati T; Mahjoub S
    Eur J Intern Med; 2008 Nov; 19(7):541-7. PubMed ID: 19013385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlates of excessive daytime sleepiness in de novo Parkinson's disease: A case control study.
    Simuni T; Caspell-Garcia C; Coffey C; Chahine LM; Lasch S; Oertel WH; Mayer G; Högl B; Postuma R; Videnovic A; Amara AW; Marek K;
    Mov Disord; 2015 Sep; 30(10):1371-81. PubMed ID: 26095202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of status redox with demographic, clinical and imaging parameters in patients with Huntington's disease.
    Peña-Sánchez M; Riverón-Forment G; Zaldívar-Vaillant T; Soto-Lavastida A; Borrero-Sánchez J; Lara-Fernández G; Esteban-Hernández EM; Hernández-Díaz Z; González-Quevedo A; Fernández-Almirall I; Pérez-López C; Castillo-Casañas Y; Martínez-Bonne O; Cabrera-Rivero A; Valdés-Ramos L; Guerra-Badía R; Fernández-Carriera R; Menéndez-Sainz MC; González-García S
    Clin Biochem; 2015 Dec; 48(18):1258-63. PubMed ID: 26210848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.